Copyright
©The Author(s) 2015.
World J Biol Chem. Nov 26, 2015; 6(4): 409-418
Published online Nov 26, 2015. doi: 10.4331/wjbc.v6.i4.409
Published online Nov 26, 2015. doi: 10.4331/wjbc.v6.i4.409
Target | Compound name |
AK | ABT-702 |
AKT (PKB) | Akt Inhibitor IV, Akt Inhibitor VIII, Akt Inhibitor XI |
AMPK | compound C |
ATM | ATM/ATR kinase inhibitor, ATM kinase inhibitor |
Aurora kinase | Aurora kinase/CDK inhibitor, aurora kinase inhibitor II, Aurora kinase inhibitor III |
Bcr-abl | AG957 |
BTK | LFM-A13, terreic acid |
CAMKII | KN-93, KN-62, Lavendustin C |
CDK | Kenpaullone, purvalanol A, Olomoucine, Alsterpaullone, Cdk1/2 inhibitor III, Cdk2/9 inhibitor, NU6102, Cdk4 inhibitor, NSC625987 |
Chk | SB218078, Isogranulatimide, Chk2 inhibitor, Chk2 inhibitor II |
CK | Ellagic acid (dihydrate), TBB, DMAT, D4476 |
Clk | TG003 |
DGK | Diacylglycerol kinase inhibitor II |
DNA-PK | IC60211 |
eEF2 kinase | TX-1918 |
EGFR | BPIQ-II, AG1478, AG490 |
FGFR | SU4984, SU5402 |
Flt-3 | Flt-3 Inhibitor |
Fms | cFMS Receptor Inhibitor |
Fyn | SU6656 |
GSK | GSK-3 inhibitor IX, 1-Azakenpaullone, Indirubin-3’-monoxime |
HER2 | AG825 |
IGF-IR | AG1024, AGL 2263 |
IKK | BMS-345541, IKK-2 inhibitor VI |
IRAK | IRAK-1/4 inhibitor |
JAK | JAK Inhibitor I, JAK3 Inhibitor VI |
JNK | SP600125, JNK inhibitor VIII |
Lck | Damnacanthal, PP2 |
MAPK | ERK inhibitor II |
MEK | PD98059, U-0126, MEK inhibitor I |
Met | SU11274 |
MLCK | ML-7 |
p38 MAPK | SB202190, SB239063 |
PDGFR | AG1296, SU11652, PDGF receptor inhibitor V, PDGF receptor inhibitor IV |
PI3K | LY-294002, Wortmannin |
PKA | H-89, 4-cyano-3-methylisoquinoline |
PKC | Bisindolymaleimide I, Go7874 |
PKG | Rp-8-CPT-cGMPS, KT5823 |
PKR | PKR inhibitor |
Raf | RAF1 kinase inhibitor I, ZM 336372 |
ROCK | H-1152, Y-27632 |
Hsp90 | radicicol |
Src | PP1 analog |
Syk | Syk inhibitor |
TGF-bRI | SB431542, TGF-beta RI kinase inhibitor II |
Tpl2 | Tpl2 kinase inhibitor |
TrKA | TrkA inhibitor |
VEGFR | VEGFR receptor inhibitor II, VEGF recptor 2 inhibitor I, SU1498 |
- Citation: Nishiya N, Sakamoto Y, Oku Y, Nonaka T, Uehara Y. JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790M. World J Biol Chem 2015; 6(4): 409-418
- URL: https://www.wjgnet.com/1949-8454/full/v6/i4/409.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v6.i4.409